• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Johnson & Johnson Strategic Analysis Profile Product Image

Johnson & Johnson Strategic Analysis Profile

  • Published: February 2008
  • 47 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Eli Lilly & Co
  • General Mills, Inc.
  • MedPointe Inc
  • Novartis
  • Sanofi-Aventis
  • MORE

- The Johnson & Johnson Strategic Analysis Profile is a comprehensive profile of the company including both quantitative and qualitative research. The report examines the Johnson & Johnsons business structure and operations, history and products, and provides an analysis of its key revenue lines. The profile provides strategic insight on the company by examining its strategy, both in terms of its value chain positioning and strategic strengths and weaknesses in form of SWOT analysis. The SWOT section studies the major internal and external factors affecting the company. In addition the profile also includes a revenue analysis section which provides a breakdown of the companys’ revenue by segment and key geographies.

Report Coverage

- Insightful company information, which addresses business and competitor intelligence needs.
- In-depth analysis of the operational aspects of the business including business descriptions, product lines and services revenue splits, and key competitors.
- Detailed financial and operational overview including key performance specific ratios.
- Strategic analysis of the company using SWOT and Value Chain analysis.
- Information READ MORE >

Johnson & Johnson Strategic Analysis Profile

TABLE OF CONTENTS

CHAPTER 1 BUSINESS DESCRIPTION6
Business Overview6
Consumer6
Overview6
Financials6
Market View6
Key Strategies6
Medical Devices and Diagnostics7
Overview7
Financials7
Market View7
Key Strategies7
Major Products and Services7
Overview7
CHAPTER 2 HISTORY9
CHAPTER 3 BUSINESS STRATEGY13
Mission Statement13
Strategy13
Corporate Social Responsibility14
Overview14
Specific CSR Initiatives14
CHAPTER 4 VALUE CHAIN ANALYSIS16
Product Development16
Overview16
Financials, Production and Major Projects16
CHAPTER 5 SWOT ANALYSIS17
Overview17
Johnson & Johnson Strengths17
Strong brand name17
Robust financial performance17
Foothold in oncology market18
Johnson & Johnson Weaknesses18
Underperformance of pharmaceutical division18
Overdependence on Risperdal18
Lack of new pipeline products18
Johnson & Johnson Opportunities19
Strategic acquisitions19
FDA clearance19
Increasing healthcare spending in the U.S19
Johnson & Johnson Threats19
Concerns related to Procrit and Eprex19
Potential failure to develop follow-up product for Topamax20
Industry consolidation20
CHAPTER 6 COMPETITORS21
CHAPTER 7 REVENUE ANALYSIS22
Revenue by Segment22
Revenue by Geography22
CHAPTER 8 FINANCIAL AND OPERATIONAL REVIEW24
CHAPTER 9 SHAREHOLDING STRUCTURE26
CHAPTER 10 KEY EMPLOYEES27
CHAPTER 11 KEY EMPLOYEE BIOGRAPHIES28
CHAPTER 12 COMPANY STATEMENT30
CHAPTER 13 LOCATIONS AND SUBSIDIARIES33
Head Office33
Other Locations & Subsidiaries33
CHAPTER 14 FINANCIAL DEALS LANDSCAPE35
CHAPTER 15 RECENT DEVELOPMENTS38
CHAPTER 16 APPENDIX47
Methodology47
About Global Markets Direct47
Contact Us47
Disclaimer47

LIST OF TABLES

TABLE 1: JOHNSON & JOHNSON,KEY FACTS, 20063
TABLE 2: JOHNSON & JOHNSON, SWOT ANALYSIS,, 20063
TABLE 3: JOHNSON & JOHNSON, SWOT ANALYSIS,, 200617
TABLE 4: JOHNSON & JOHNSON, REVENUE BY SEGMENT, USD MILLION, 2005-200622
TABLE 5: JOHNSON & JOHNSON, REVENUE BY GEOGRAPHY, USD MILLION, 2005-200623
TABLE 6: JOHNSON & JOHNSON FINANCIAL AND OPERATIONAL OVERVIEW, 2006-200224
TABLE 7: JOHNSON & JOHNSON FINANCIAL AND OPERATIONAL OVERVIEW, 2006-2002 (CONTD.) 25
TABLE 8: JOHNSON & JOHNSON, 200626 J74
TABLE 9: JOHNSON & JOHNSON,KEY EMPLOYEES, 200627
TABLE 10: JOHNSON & JOHNSON,KEY EMPLOYEES, 2006 (CONTD.) 28
TABLE 11: JOHNSON & JOHNSON, SUBSIDIARIES33
TABLE 12: JOHNSON & JOHNSON, SUBSIDIARIES( CONTD.) 34

LIST OF FIGURES

FIGURE 1: JOHNSON & JOHNSON, VALUE CHAIN ANALYSIS16

The following companies are the major competitors of Johnson & Johnson:

Abbott Laboratories
AstraZeneca International plc
Beiersdorf AG
Boston Scientific Corporation
Bristol-Myers Squibb Company
Eli Lilly & Co
General Mills, Inc.
GlaxoSmithKline plc
MedPointe Inc
Merck & Co., Inc.
Novartis
Pfizer, Inc.
The Procter & Gamble Company
F. Hoffmann-La Roche Ltd.
Sanofi-Aventis
Unilever
Wyeth

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos